The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo
Abstract
Theranostic nanomedicine is capable of diagnosis, therapy, and monitoring the delivery and distribution of drug molecules and has received growing interest. Herein, a self-monitored and self-delivered photosensitizer-doped FRET nanoparticle (NP) drug delivery system (DDS) is designed for this purpose. During preparation, a donor/acceptor pair of perylene and 5,10,15,20-tetro (4-pyridyl) porphyrin (H2TPyP) is co-doped into a chemotherapeutic anticancer drug curcumin (Cur) matrix. In the system, Cur works as a chemotherapeutic agent. In the meantime, the green fluorescence of Cur molecules is quenched (OFF) in the form of NPs and can be subsequently recovered (ON) upon release in tumor cells, which enables additional imaging and real-time self-monitoring capabilities. H2TPyP is employed as a photodynamic therapeutic drug, but it also emits efficient NIR fluorescence for diagnosis via FRET from perylene. By exploiting the emission characteristics of these two emitters, the combinatorial drugs provide a real-time dual-fluorescent imaging/tracking system in vitro and in vivo, and this has not been reported before in self-delivered DDS which simultaneously shows a high drug loading capacity (77.6%Cur). Overall, our carrier-free DDS is able to achieve chemotherapy (Cur), photodynamic therapy (H2TPyP), and real-time self-monitoring of the release and distribution of the nanomedicine (Cur and H2TPyP). More importantly, the as-prepared NPs show high cancer therapeutic efficiency both in vitro and in vivo. We expect that the present real-time self-monitored and self-delivered DDS with multiple-therapeutic and multiple-fluorescent ability will have broad applications in future cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Cited by
High drug-loading nanomedicines: progress, current status, and prospects
Shen, S., Wu, Y., Liu, Y., & Wu, D. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132780 · Cited by 618
Drug self-delivery systems for cancer therapy
Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532
Self-citationCarrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy
Zhang, R., Xing, R., Jiao, T., Ma, K., Chen, C., Ma, G., & Yan, X. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02416 · Cited by 318
Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics
Pan, X., Wang, H., Wang, S., Sun, X., Wang, L., Wang, W., Shen, H., & Liu, H. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9262-x · Cited by 302
Ultralow-Power Near Infrared Lamp Light Operable Targeted Organic Nanoparticle Photodynamic Therapy
Huang, L., Li, Z., Zhao, Y., Zhang, Y., Wu, S., Zhao, J., & Han, G. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05390 · Cited by 301
Tian, H., Zhang, M., Jin, G., Jiang, Y., & Luan, Y. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.12.028 · Cited by 283
Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy
Fu, S., Li, G., Zang, W., Zhou, X., Shi, K., & Zhai, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.012 · Cited by 266
Li, Y., Liu, G., Ma, J., Lin, J., Lin, H., Su, G., Chen, D., Ye, S., Chen, X., Zhu, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.011 · Cited by 255
Self-citationHuang, L., Zhao, S., Fang, F., Xu, T., Lan, M., & Zhang, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120557 · Cited by 254
Self-citationChen, T., He, B., Tao, J., He, Y., Deng, H., Wang, X., & Zheng, Y. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.009 · Cited by 186
Nanoformulations for combination or cascade anticancer therapy
Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178
NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
Li, M., Sun, X., Zhang, N., Wang, W., Yang, Y., Jia, H., & Liu, W. (2018) · Advanced Science · doi:10.1002/advs.201800155 · Cited by 153
Zhang, N., Li, M., Sun, X., Jia, H., & Liu, W. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.007 · Cited by 136
Fang, F., Wang, S., Song, Y., Sun, M., Chen, W.-C., Zhao, D., & Zhang, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37315-0 · Cited by 112
Self-citation
Metadata
- Authors
- Zhang, J., Liang, Y.-C., Lin, X., Zhu, X., Yan, L., Li, S., Yang, X., Zhu, G., Rogach, A. L., Yu, P. K. N., Shi, P., Tu, L.-C., Chang, C.-C., Zhang, X., Chen, X., Zhang, W., & Lee, C.-S.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-09-25
- Volume
- 9
- Issue
- 10
- Pages
- 9741-9756
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2199392936
- Cited by
- 169
- References
- 2
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.